The 17q23 Amplicon and Breast Cancer

Author： Sinclair C.S.   Rowley M.   Naderi A.   Couch F.J.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.78, Iss.3, 2003-04, pp. : 313-322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression levels of HER2/neu and those of collocated genes at 17q12-21, in breast cancer

By Glynn Ronan W.   Miller Nicola   Mahon Sarah   Kerin Michael J.  

Oncology Reports, Vol. 28, Iss. 1, 2012-07 ,pp. : 365-369

Spandidos Publications

Access to resources Recommend Favorite

Effect of Rab23 on the proliferation and apoptosis in breast cancer

By              

Oncology Reports, Vol. 34, Iss. 4, 2015-01 ,pp. : 1835-1844

Spandidos Publications

Access to resources Recommend Favorite

Chromosome 17q25 genes, RHBDF2 and CYGB, in ovarian cancer

By Wojnarowicz Paulina M.   Provencher Diane M.   Mes-Masson Anne-Marie   Tonin Patricia N.  

International Journal of Oncology, Vol. 40, Iss. 6, 2012-06 ,pp. : 1865-1880

Spandidos Publications

Access to resources Recommend Favorite

Genetic polymorphism in CYP17 and breast cancer risk in Japanese women

By Miyoshi Y.   Iwao K.   Ikeda N.   Egawa C.   Noguchi S.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2375-2379

Elsevier

Access to resources Recommend Favorite

CMTM1_v17 is a novel potential therapeutic target in breast cancer

By                

Oncology Reports, Vol. 32, Iss. 5, 2014-01 ,pp. : 1829-1836

Spandidos Publications

Access to resources Recommend Favorite